Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|35|6|613-630

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.6, 2015-06, pp. : 613-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: differentiating chronic idiopathic constipation from constipation‐predominant irritable bowel syndrome – possible and important? – Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1300-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: differentiating chronic idiopathic constipation from constipation‐predominant irritable bowel syndrome – possible and important?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1299-1299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tegaserod in the treatment of irritable bowel syndrome with constipation

By Saad Richard   Chey William D  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 29-42

Future Medicine

Access to resources Recommend Favorite

Editorial: fibre and FODMAPs in constipation and irritable bowel syndrome

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 383-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation

By Johnston Jeffrey M.   Shiff Steven J.   Quigley Eamonn M.M.  

Current Medical Research and Opinion, Vol. 29, Iss. 2, 2013-02 ,pp. : 149-160

Informa Healthcare

Access to resources Recommend Favorite